Marion Webb has been writing about health care issues for nearly two decades as a full-time reporter and freelancer. As the senior business reporter for the San Diego Business Journal, Marion covered new medical innovations at San Diego’s top-ranking research institutions and the medical device and life sciences industry for nearly eight years. She’s also been a regular contributor to the Los Angeles County Medical Association’s Physician Magazine and Physicians News Network focusing on new technologies, practice management, reimbursement and other trendy issues relevant to physician practices and their ability to succeed. She remains fascinated by the ever-growing numbers of innovative products coming out of the medtech sector, from potentially life-saving devices to help treat patients who otherwise wouldn’t have access to medical care to breakthrough technologies that benefit mankind. Marion earned her BA in communications from UC San Diego and continues to enjoy an active lifestyle in San Diego.
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Marion Webb
More than 75% of Fortune 500 life-science companies may fall out of that ranking by 2023 amid rising competition from tech giants like Apple, Microsoft and Alphabet, as well as smaller tech players that offer data-driven health services and products that meet the needs of a changing value-based and consumer-driven health-care environment, according to a new Ernst & Young report.
Market Intel: Medtronic, Philips, Masimo, And Others Keep Pulse Beating In Oximetry Patient Monitoring Market
Demand for reliable, accurate, high-quality pulse oximetry devices in and – increasingly – outside hospitals is driven by the rise of chronic diseases, a growing elderly population prone to asthma, heart disease, sleep apnea and chronic obstructive pulmonary disease, as well as the need to monitor oxygen levels in premature babies. According to a new report by Meddevicetracker, the global market for standalone, hospital-grade pulse oximetry devices and accessories will reach $1.9bn by 2021, a CAGR of 5.4% from 2016. In this feature, we'll take a closer look at the overall pulse oximetry market, the major players and which forces are driving – and stymying – its growth.
Stryker is enjoying strong demand for its MAKO robotic surgery platform with plans to increase system placements and procedure volumes while working on a next-gen system that would enhance ease-of-use for surgeons and improve accuracy. The company also has plans to expand into other areas of focus, according to analyst reports from this year's AAOS annual meeting in New Orleans. Meanwhile, Smith & Nephew and Zimmer Biomet are trying to set themselves apart with their robotic technologies.
In this edition of the Device Week podcast, Medtech Insight’s Reed Miller and Marion Webb discuss medtech’s role in combatting rheumatoid arthritis and they highlight some recent clinical trial initiations and completions.
When it comes to treating acute heart attack patients, primary percutaneous coronary intervention (PPCI) remains the gold standard of care. And while this life-saving procedure restores blood flow through the coronary artery, perfusion in all areas of the heart may not occur. In this article, we'll highlight three innovative medtech companies that have developed very different solutions to try to improve upon the current standard of care and hear perspectives from interventional cardiologists.
In this episode of Device Week, Medtech Insight’s Reed Miller chats to Marion Webb about the most interesting presentations by the key spinal cord stimulation players at this year’s NANS meeting in Las Vegas, and also finds out from Tina Tan how the venture financing climate has been for start-ups in January.